Continuous Glucose Monitoring in Insulin-Treated Type 2 Diabetes Mellitus in Sweden: A Scoping Review and Policy Landscape Analysis - PubMed
5 hours ago
- #Medical Technology
- #Diabetes Management
- #Health Policy
- Type 2 diabetes in Sweden is a major chronic disease, making continuous glucose monitoring (CGM) a key alternative to traditional glucose monitoring.
- CGM is associated with better clinical outcomes, including fewer long-term complications and reduced healthcare costs, compared to self-monitoring of blood glucose.
- Sweden's CGM access is limited and varies by region, with recommendations not fully covering all insulin-treated T2DM patients, highlighting inequities in care.
- The review suggests expanding Swedish guidelines to include all insulin-treated individuals to improve access and address regional disparities effectively.